Florbetapir positron emission tomography and cerebrospinal fluid biomarkers
Abstract
We evaluated the relationship between florbetapir‐F18 positron emission tomography (FBP PET) and cerebrospinal fluid (CSF) biomarkers.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 24, 2015
- Source ID
- 10.1016/j.jalz.2015.03.002
Entities
People
- Ann Hake
- Elisabeth K. Degenhardt
- Helen Hochstetler
- Michael Case
- Michael M. Witte
- Paula T. Trzepacz
- Peng Yu
- Robert A. Dean
- Shufang Wang
- The Alzheimer’s Disease Neuroimaging Initiative*
Organizations
- Alzheimer's Disease Neuroimaging Initiative
- Eli Lilly and Company
- Foundation for the National Institutes of Health
- Indiana University
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- United States Department of Defense